常见的F5的VTE保护性G单元型增加了V-short因子,TFPI功能和出血风险
Matthew C Sims1,2,3,4, Magdalena Gierula5, Jonathan C Stephens1,6
1Department of Haematology, University of Cambridge, Cambridge, United Kingdom.
Blood advances
|October 4, 2024
概括
F5 G 单体型通过增加因子V (FV-short) 来降低静脉血栓栓塞 (VTE) 风险. 这种由FV-short和组织因子抑制剂α (TFPI) 介导的机制也会增加出血风险.
科学领域:
- 遗传学和分子生物学
- 血液学 血液学 血液学
- 药物基因组学 药物基因组学
背景情况:
- 在F5基因中的G类型与静脉血栓塞栓症 (VTE) 风险降低有关.
- 尽管G单元型的流行程度很高,但G单元型的保护机制仍然不太清楚.
- 一种因子V (FV) 异型的FV-short与出血障碍和增加组织因子抑制剂α (TFPIα) 水平有关.
研究的目的:
- 调查由F5 G原型所赋予的VTE保护的潜在机制.
- 为了确定G型单双形携带者是否表现出改变的FV短拼接和血水平.
- 探索G单双型,FV短型,TFPI和血栓生成之间的关联.
主要方法:
- 从INTERVAL研究中对献血者进行RNA测序,以检测拼接变异.
- 通过基因型回忆血分析量化FV-short和FV总水平.
- 分析G型单体携带者和对照群体中血栓生成滞后时间和TFPI水平.
- 大规模的英国生物库数据分析,以将G单元型与VTE和出血事件相关联.
主要成果:
- 在F5-G/G个体中观察到FV短拼接部位罕见切除事件的频率显著更高.
- 与F5-ref对照组相比,F5-G/G参与者的血FV-short水平大约是F5-G/G参与者的2.2倍.
- 在F5-G/G个体中,TFPI依赖的血栓生成延迟时间增加了1.4倍.
- 证实G类型对VTE有保护作用,但也与出血发作风险增加有关.
结论:
- F5 G单元型的VTE保护作用是由增加的FV-short水平介导的.
- FV-short/TFPI通路在由G单元型影响的静血平衡中起着至关重要的作用.
- G 单形呈现双重效应,提供对VTE的保护,同时增加出血风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
636
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
636
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Disorders of Hemostasis
738
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
738
Extrinsic and Intrinsic Pathways of Hemostasis
6.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.3K
Coagulation
5.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
5.4K
Venous Thrombosis I: Introduction
3
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
3


